Karen Krikorian
Psychiatric/Mental Health · Seattle, WANPI 1801235486
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 87 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,134, 7.9 times the $143 reported in 2023.
Across 87 payments — averaging $24.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$498
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$310
- Dexcom, Inc.$126
- Novo Nordisk$123
- Bausch Health US, LLC$120
- Kowa Pharmaceuticals America, Inc.$119
- plus $804 from 21 others
What the payments were for
- Food & beverage$2,099100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 26 | $498 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $310 |
| Dexcom, Inc. | 4 | $126 |
| Novo Nordisk | 5 | $123 |
| Bausch Health US, LLC | 5 | $120 |
| Kowa Pharmaceuticals America, Inc. | 4 | $119 |
| Johnson & Johnson | 3 | $103 |
| Abbott | 3 | $89 |
| AbbVie | 3 | $86 |
| Exact Sciences | 2 | $50 |
| Lilly USA, LLC | 2 | $46 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
| Tris Pharma Inc | 2 | $38 |
| Philips North America LLC | 1 | $38 |
| Hologic Sales And Service, LLC | 1 | $31 |
| Bayer | 1 | $29 |
| Edwards Lifesciences | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Medtronic | 1 | $26 |
| Seqirus USA Inc | 1 | $25 |
| Pfizer | 1 | $24 |
| Qiagen, LLC | 1 | $24 |
| Phadia US Inc. | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| AstraZeneca | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
How this compares
$2,099 in reported general payments places this provider in the 85th percentile of 931 psychiatric/mental health providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lorazepam | 12 | $121 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Seattle
- Kelly BlissSeattle$18K
- Anthony DelosreyesSeattle$9K
- Shannon JacksonSeattle$8K
- Emma NaumanSeattle$4K
- Angela CombsRichland$121K
- Ashley McGinnisAuburn$26K
- Courtney YantPuyallup$26K
- Dawn MasonSpokane$25K
- Jennifer WilsonYakima$23K
- Kojo SarfoEllensburg$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.